Prof. Antonio Dal Canton
Professore Ordinario di Nefrologia e Direttore della Scuola di Specializzazione
Università degli Studi di Pavia

Curriculum vitae

Birth Place and Date: Parma, December 17, 1945.

 

Address: Fondazione IRCCS Policlinico San Matteo, Piazzale Golgi 2, 27100 Pavia, Italy.

Telephone Number: +39 (1139 from USA) 0382-422037

CURRENT POSITION: Director, since 1987.

Title: Professore Ordinario (Full Professor) of Nephrology, since 1986.

University: Faculty of Medicine, Pavia.

Hospital: Policlinico San Matteo, Pavia

PREVIOUS POSITIONS:

1971-1977 (October): Assistant, Dpt. Internal Medicine, University of Parma.

1977-1986 (October): Deputy Director (Aiuto), Unit of Nephrology, University of Naples.

1986-1987 (March): Full Professor (Professore Ordinario) of Nephrology, University of Sassari

1987-1992 (October): Full Professor of Nephrology and Director, Unit of Nephrology, University of Reggio Calabria at Catanzaro.

1992- today: Full Professor of Nephrology, University of Pavia.

1995 (October)  Director of Unit of Nephrology Dialysis Transplantation, Policlinico San Matteo, Pavia.

APPOINTMENTS:

1984-87: Council Member, European Dialysis Transplant Association - European Renal Association.

1998-2001: Council Member, Italian Society of Nephrology.

1989-1992: Director, School of Specialization in Nephrology, University of Reggio Calabria at Catanzaro.

1995-today: Director, School of Specialization in Nephrology, University of Pavia.

1995-today: UEMS  (Union European Medical Representative) Italian representative, Nephrology Section.

2000-2007: Referee, CME program, Italian Ministero della Salute.

2008-2010: President, Italian Society of Nephrology (Società Italiana di Nefrologia)

2010-today: Dean, University of Pavia School of Medicine

 

RELEVANT CLINICAL RESEARCH EXPERIENCE

Troughout the career:

      -     physiology of glomerular hemodynamics (renal micropuncture)

  • pathophysiology and therapy of water and salt retention
  • pathophysiology and therapy of hypertension
  • pathophysiology and therapy of acute and chronic renal failure, including renal replacement therapy with dialysis and transplantation
  • growth factors in renal physiology and disease

[Torna allo staff] [top]

 

MAIN PUBLICATIONS

(impact factor > 3)

Morphologic identification of microperfused-fixed single nephrons during renal micropuncture. Kidney International 5:300-302, 1974

(4,773)

 

Reliability of radioactive inulin as a marker of glomerular filtration rate in the rat. Pflugers Arch. 1974;350(4):347-58.

(4.807)

 

Role of efferent arteriole in glomerular hemodynamics. Kidney International 9:475-480, 1976

(4,773)

 

Effects of acute ureteral obstruction on glomerular hemodynamics in rat kidney. Kidney International 12:403-411, 1977

(4,773)

Effects of 24-hour unilateral ureteral obstruction on glomerular dynamics in rat kidney. Kidney Internatinal 15:457-462, 1979

(4.773)

 

Glomerular hemodynamics before and after release of 24 hour bilateral ureteral obstruction Kidney International 17:491-496, 1980

(4,773)

 

Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease. British Medical Journal 282:595-598, 1981

(9.245)

Effects of pregnancy on glomerular dynamics. Micropuncture study in the rat. Kidney International  22:608-612, 1982

(4.773)

 

Usefulness of hypnosis for carrying out renal needle biopsy in children. Kidney International 26: 351-352, 1984

(4,773)

Mechanism of impaired concentration in chronic primary glomerulonephritis. Kidney International 27:792-798, 1985.

(4.773)

Diuretic therapy in uremic patients. Kidney International 28: 154-156, 1985

(4.773)

 

Mechanism of increased plasma urea after diuretic therapy in uraemic patients. Clin Sci (Lond). 1985 Mar;68(3):255-61.

(3.263)

Polyuric prerenal failure after reduction from high to normal dietary saline intake. Archives of Internal Medicine 9: 1814-1816, 1986.

(7.92)

Captopril and impaired renal function. Annals of Internal Medicine 104:263, 1986.

(14.78)

Renal handling of urea in subjects with persistent azotemia and normal renal function. Kidney International 32:721-727, 1987.

(4,773)

 

Percutaneous renal embolization in renovascular hypertension. British Medical Journal 296:1160-1161, 1988

(9.245)

Theory of urine formation and uroscopic diagnosis in the medical school of Salerno. Kidney International 34:273-277, 1988.

(4.773)

Acute cyclosporine dysfunction reversed by dopamine infusion in healthy subjects. Kidney International 36:1086-1092, 1989

(4.773)

 

Glomerular dynamics and salt balance in pregnant rats with renal hypertension. American Journal of Physiology 256: F728-F734, 1989.

(4.199)

 

Reversibility of acute cyclosporin nephrotoxicity by dopamine. Micropuncture study in the rat. Nephrol Dial Transplant. 4(5):327-33, 1989.

(3.154)

 

Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal disease. Kidney International 38:301-307, 1990

(4.773)

Role of atrial natriuretic factor in renal adaptation to variation of salt intake in humans. American Journal of Physiology 258: 1579-1583, 1990

(4.199)

 

Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat. Nephrol Dial Transplant. 5(1):69-74, 1990.

(3.154)

 

Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. Nephrol Dial Transplant. 6: Suppl 2:96-8, 1991.

(3.154)

Mesangial expression of intercellular adhesion molecule-1 in primary glomerulosclerosis. Kidney International 41:220-224, 1992.

(4.773)

 

Role of inhibition of atrial natriuretic factor release in the down- regulation of salt excretion. Kidney International 42: 673- 680, 1992.

(4.773)

 

Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells.  Kidney International  42: 320-326, 1992

(4.773)

 

Extra-natriuretic effects of atrial natriuretic peptide in humans. Kidney International 43: 307- 313, 1993

(4.773)

Prevalence of symptoms in patients with simple renal cysts.  British  Medical Journal 306: 430-431, 1993.

(9.245)

 

Interleukin-6 production induced in peripheral blood mononuclear cells by a serum factor from IgA nephropathy patients is inhibited in vitro by specific sugars. Nephrol Dial Transplant. 9(11):1560-3, 1994.

(3.154)

 

Adhesion molecules in renal disease. Kidney International 48:1687-1696, 1995.

(4,773)

Serial morphometric analysis of sclerotic lesions in primary focal segmental glomerulosclerosis.  Journal American Society Nephrology 7:49-55, 1996

(7.371)

Effects of age on the role of atrial natriuretic factor in renal adaptation to physiologic variations of dietary salt intake. Journal American Society Nephrology 7:1045-1051, 1996

(7.371)

Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells. Journal  American  Society Nephrology 8: 208-213, 1997.

(7.371)

Hemodialysis stimulates hepatocyte growth factor release. Kidney International 53: 1382-8, 1998.

(4.773)

 

Hemodialysis prevents liver disease caused by hepatitis C virus: role of Hepatocyte Growth Factor. Kidney International 56: 2286-2291, 1999.

(4.773)

 

Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney International 58:123-130, 2000.

(4.773)

 

Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney International 59:1842-1849, 2001.

(4.773)

 

Polarization of T-Helper lymphocytes toward the Th2 phenotype in uremic patients. American Journal Kidney Disease 38:286-295, 2001

(4.072)

 

Hepatocyte Growth Factor/Scatter Factor released during peritonitis is active on mesothelial cells. American Journal of Pathology 159:1-11, 2001.

(5.917)

Macrophage-Stimulating protein is produced by tubular cells and activates mesangial cells. Journal of the American Society of Nephrology 13:649-657, 2002.

(7.371)

 

Hypercarotenemia. New England Journal of Medicine 346:821, 2002

(51.296)

 

Lunch-related polyuria. American Journal of Kidney Disease 40:218-9, 2002.

(4.072)

 

Correlation between hyperhomocysteinemia and interleukin-18 serum levels in maintenance hemodialyzed patients. - Kidney International 62: 1900, 2002.

(4.773)

Inverse association between homocysteine and vascular endothelial growth factor receptor serum levels in hemodialyzed and kidney transplanted patients. Kidney International 64(5):1922, 2003.

(4.773)

 

Prevalence of hyperhomocysteinemia in male hemodialysis patients. Kidney International 64:1531, 2003.

(4.773)

Peritoneal dialysis and epithelial-to-mesenchymal transition. New England Journal of  Medicine. 348:2037-9, 2003

(51.296)

The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma. American  Journal of Surgical Pathology 27:779-85, 2003.

(4.144)

 

Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients. Kidney International 65:1473-81, 2004

(4.773)

 

A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation 2004 77: 1540-5, 2004.

(3.972)

 

Mycophenolate mofetil in IgA nephropathy. Kidney International 66:1713, 2004

(4.773)

 

Hepatocyte growth factor modulates matrix turnover in human glomeruli. Kidney International. 67:2143-50, 2005.

(4.773)

C-reactive protein and coronary artery disease in hemodialyzed patients. Kidney International 68:1374-5, 2005.

(4.773)

 

Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis. Nephrol Dial Transplant. 20(6):1066-74, 2005.

(3.154)

B-type natriuretic peptide dialysis clearance and renal function in patients with decompensated heart failure. American Journal of  Kidney Disease 47:562-3, 2006.

(4.072)

 

Henle loop basement membrane as initial site for randall plaque formation. American Journal of Kidney Disease 48:706-11, 2006.

(4.072)

 

The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo. Kidney International. 72:114-120, 2007

(4.773)

 

Neutralization of Macrophage-Stimulating Protein Ameliorates Renal Injury in Anti-Thy 1 Glomerulonephritis. Journal American Society of Nephrology 18:1486-96, 2007

(7.371)

 

Folic acid for stroke prevention. Lancet. 2007 370(9588):651, 2007

(25.8)

 

Burnout in health care providers of dialysis service in Northern Italy a multicentre study. Nephrol Dial Transplant 22(8):2283-90, 2007

(3.154)

 

Prevention of dialysis hypotension episodes using fuzzy logic control system. Nephrol Dial Transplant. 22(5):1420-7, 2007

(3.154)

Risk factors for chronic renal dysfunction in lung transplant recipients. Transplantation 84(12):1701-3, 2007.

(3.972)

Mycophenolate mofetil in primary glomerulopathies. Kidney Int 73(2):154-62. Epub 2007 Nov 7.

(4.773)

 

Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol Dial Transplant. 22(7):2013-9, 2007. (3.154)

Prevention of dialysis hypotension episodes using fuzzy logic control system. Nephrol Dial Transplant. 2007 May;22(5):1420-7 

 

Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-thy 1 glomerulonephritis. J Am Soc Nephrol. 2007 May;18(5):1486-96.

The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo. Kidney Int. 2007 Jul;72(1):114-20.

Burnout in health care providers of dialysis service in Northern Italy--a multicentre study. Nephrol Dial Transplant. 2007 Aug;22(8):2283-90.

Folic acid for stroke prevention. Lancet. 2007 Aug 25;370(9588):651

Mycophenolate mofetil in primary glomerulopathies.

Kidney Int. 2008 Jan;73(2):154-62.

Clinical policies on the management of chronic kidney disease patients in Italy. Nephrol Dial Transplant. 2008 Feb;23(2):621-6.

Risk factors for chronic renal dysfunction in lung transplant recipients. Transplantation. 2007 Dec 27;84(12):1701-3.

KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells. Growth Factors. 2007 Dec;25(6):382-91.

 

Severe symptomatic hyponatremia during sibutramine therapy: a case report. Am J Kidney Dis. 2008 Jul;52(1):137-9.

 

Scatter Factors in renal disease: Dr. Jeckyll and Mr. Hyde? Cytokine Growth Factor Rev. 2009 Feb;20(1):77-85.

 

Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int. 2009 Mar;75(5):536-41

 

The antifibrogenic effect of hepatocyte growth factor (HGF) on renal tubular (HK-2) cells is dependent on cell growth. Growth Factors. 2009 Jun;27(3):173-80

 

Quiz page August 2009: Respiratory distress 5 years after kidney transplantation. Am J Kidney Dis. 2009 Aug;54(2):A35-7

 

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009 Nov 19;361(21):2019-32

 

Everolimus with very low-exposure cyclosporine a in de  novo kidney transplantation: a multicenter, randomized, controlled trial. Transplantation. 2009 Nov 27;88(10):1194-202

 

Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol. 2010 Jan;159(1):73-81.

 

Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy. Br J Clin Pharmacol. 2010 Jan;69(1):38-50

 

Revascularization for renal-artery stenosis. N Engl J Med. 2010 Feb 25;362(8):762-3.

 

Autoimmune response to heat shock protein 60 in haemodialysis patients. J Intern Med. 2010 Apr;267(4):440

 

Dialysis treatment and regulatory T cells. Nephrol Dial Transplant. 2010 May;25(5):1723-7

 

Renal Blood Flow Redistribution During Acute Kidney Injury. Am J Kidney Dis. 2010 Jun 26. [Epub ahead of print]

 

Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors. Clin Sci (Lond). 2010 Jun 28. [Epub ahead of print]




[Torna allo staff] [top]